www.lifecodes.com/
·
Cached
·
Save
CombiMatrix Corporation - Custom
DNA Microarrays, Biothreat ...Develops proprietary
DNA microarrays technologies for genomics, proteomics, and gene expression applications, which have uses in ...
DNA Diagnostics Home Page
DNA Diagnostics Ltd is a joint venture between Auckland Uniservices (the commercial arm of the University of Auckland) and Diagnostic Medlab.View Details On
DNA Paternity Testing Centers in China and Hong KongLtd, -- Yesu Biotech Company Ltd, --
DNA Diagnostics Center (DDC), -- Shenzhen Tai Tai Genomics Inc, -- The Judging center for Forensic ...related
DNA Diagnostic Center, Blood
DNA Tests,
DNA Testing Labs, Paternity Test, James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development... from his position as Vice President of Research and Development for Veridex LLC, a
Johnson & Johnson cancer diagnostics company and center of excellence for molecular diagnostics and genomics. Prior to joining Johnson & Johnson, Dr. Godsey was ... Gentris Corporation Announces FDA 510(k) Submission for GentriSureA ...... product solutions, today announced that the company has completed an FDA 510(k) submission for six Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6). Under the GentriSure brand, the six products include: CYP2D6 ... Roche Oral Polymerase Inhibitor R1626 Shows Strong Antiviral Activity ...... is known to cause anemia (low red blood cells), which can make heart disease worse. Also, ribavirin can harm your DNA and possibly cause cancer (see medication guide for more information and warnings). Who should not take PEGASYS and COPEGUS? Do not ... Customizing Treatment with PEGASYS(R) May Improve Chances for Success in Hepatitis C... is known to cause anemia (low red blood cells), which can make heart disease worse. Also, ribavirin can harm your DNA and possibly cause cancer (see medication guide for more information and warnings). Who should not take PEGASYS and COPEGUS? Do not ... Qiagen launches kit to accelerate PCR... of genetic fingerprints, the diagnosis of infectious diseases, the cloning of genes, paternity testing, and DNA computing. Qiagen has said this kit has not been cleared by any regulatory body for use in human diagnostics or any other clinical ... The Battle Against The Big C Gets Personal... can be used in tandem with certain targeted drugs, such as AstraZeneca 's (AZN) Iressa, Genentech 's (DNA) Herceptin and Avastin and ImClone 's (IMCL) Erbitux. "With the new drugs available, we can create a very ... Gentris Corporation Announces FDA 510(k) Submission for GentriSure...... product solutions, today announced that the company has completed an FDA 510(k) submission for six Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6). Under the GentriSure brand, the six products include: CYP2D6 ... Gentris seeks Fda Ok for test control product... used drugs. The Morrisville-based firm said it has completed its
FDA marketing application for six of its Human Genomic DNA Reference Controls for CYP2D6, a liver enzyme used in the metabolism of approximately 20 percent of all commonly prescribed ... an Informatic Approach to Estimating Ecological Risks Posed by...... extrapolation, complex chemical mixtures and dose-response assessment. Area 2, Ecological Research-Environmental Diagnostics: Development of molecular diagnostic indicators contributes to several of the GPRA Diagnostic Research Goals. Methods will ... SPOTLIGHT on : VIASPACE Inc.... services, and research and development in genetics and related fields. The company's 'non-coding' DeoxyriboNucleic Acid (DNA) technology is utilized to analyze genetic material and also to map genes and traits of interest in multicellular species. ... Hugin Ad Hoc Announcement According to Section 15 WpHG: Misc....Epigenomics AG , a German listed biotech company focusing on molecular diagnostics, today announced that it has completed an internal review of current operations in the context of its defined business ... BB Medtech: Quarterly Report as at September 30, 2006... where we see high growth potential as exemplified by the most recent addition, Qiagen, in the area of molecular diagnostics. Geographically our focus will remain in Europe, however, we are in the process of evaluating individual companies in the USA ... VaxInnate Secures $40 Million Series C Financing... VaxInnate will use its TLR technology platform to produce vaccines by simple, low-cost, highly-scalable recombinant DNA techniques, avoiding the pitfalls of egg-based or cell-culture
influenza vaccine production. The company's TLR technology ... Sequenom Expands Non-Invasive Prenatal Diagnostic Testing Opportunity... testing portfolio we are developing." About
SEQUENOM's Prenatal Initiatives Sequenom's opportunity in prenatal diagnostics builds on its core technology for the genetic analysis research market and is greatly strengthened by the broad intellectual ... 454 Sequencing Reveals New Pathway in RNA Interference... conducted by
Cold Spring Harbor Laboratory, has revealed the dual role of the ARGONAUTE 4 protein (AGO4) in RNA-directed DNA methylation. The research, which describes a method for obtaining a comprehensive view of the total small RNAs from a single ... 454 Sequencing(TM) Reveals New Pathway in RNA InterferenceApplication by
Cold Spring Harbor Laboratory Yields New Insights on DNA Methylation BRANFORD, Conn., Oct. Research Team Identifies Human 'memory Gene'... at Arizona's Banner Alzheimer's Institute, Mayo Clinic Scottsdale, and the Arizona Alzheimer's Consortium, collected DNA samples from cognitively healthy people and measured memory performance. TGen researchers screened the collected DNA samples ... Affymetrix 500K Array Used To Identify Memory Gene... associated with memory performance. The team at TGen used Affymetrix Human Mapping 500K Arrays to analyze 500,000 DNA markers simultaneously, providing a genetic blueprint for the memory-study participants. The researchers discovered the Kibra gene ... Frost & Sullivan Acclaims bioMerieux's Ingenious Product,...PALO ALTO, Calif., Oct. 24 /PRNewswire/ -- Frost & Sullivan selected bioMerieux as the recipient of the 2006 Product Innovation Award for its NucliSENS easyMAG in the North American clinical diagnostics market.
